
GE
Funder
8 Projects, page 1 of 2
Open Access Mandate for Publications and Research data assignment_turned_in Project2024 - 2029Partners:INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA, CERTH, UPM, Novo Nordisk, HUMANITAS MIRASOLE SPA +24 partnersINFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA,CERTH,UPM,Novo Nordisk,HUMANITAS MIRASOLE SPA,Johnson & Johnson (United States),Janssen (Belgium),VHIO,EMBL,HUS,PATVOCATES GMBH,University of Vienna,DNV,MATICAL INNOVATION SL,TRAIN SRL,HULAFE,BSC,i-HD,FHG,Charité - University Medicine Berlin,ERASMUS MC,European Alliance for Personalised Medicine,PFIZER INC,VHIR,UNIBO,GATES VENTURES LLC,LUMC,GE,BMSFunder: European Commission Project Code: 101172872Overall Budget: 22,415,500 EURFunder Contribution: 12,438,800 EURSYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in healthcare applications. The project will improve the methodological and technical aspects of SD Generation (SDG) by developing new techniques and advancing established ones for different data modalities, including genomics and imaging, to improve the generation of realistic multimodal and longitudinal data. This project will provide the research community with approaches for transparent benchmarking of alternative SDG methods for specific applications, identify and establish evaluation metrics and methodologies, and contribute to the standardisation of an evaluation assessment framework for SD. Robust evidence of SD applicability in a set of use cases across a broad spectrum of medical conditions will be crucial to demonstrate the potential of SD to accelerate data-driven solutions of equivalent quality to those derived from real patient data. Furthermore, legal and regulatory implications of SD use will be analysed with the aim of delivering an assurance framework to guide secure SD utilization in healthcare. These significant breakthroughs will be implemented through the open SYNTHIA federated platform, facilitating responsible SD use by the health research community. The platform will facilitate users´ long-term access to extensively validated, reusable synthetic datasets, as well as to SDG workflows and SD assessment frameworks. The federated infrastructure will rely on extended open-source frameworks for interoperability with other data-sharing infrastructures in the context of the European Health Data Space. A multidisciplinary collaboration of SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and communication experts will provide a 360º vision on how to advance healthcare applications through SD use.
more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2021 - 2024Partners:Institut Pasteur, IDEAS SCIENCE NONPROFIT KFT, University of Łódź, DMI ASSOCIATES, Komenda Stoleczna Policji +4 partnersInstitut Pasteur,IDEAS SCIENCE NONPROFIT KFT,University of Łódź,DMI ASSOCIATES,Komenda Stoleczna Policji,Sioux Technologies b.v.,DATASENSELABS KFT,Polytechnic University of Milan,GEFunder: European Commission Project Code: 101021723Overall Budget: 4,374,900 EURFunder Contribution: 4,374,900 EURHoloZcan brings a new tool for security actors (police, relief workers, disaster managers, crisis managers, stakeholders responsible for public safety, critical infrastructure, and service providers) notably in the fields of autonomous detection and response capabilities. The project will increase (environmental and exhaled) bio-aerosol sensing/measurement capability of CBRN practitioners by developing a high resolution, large throughput, automatic and highly portable detection system for making automatic classification of pathogens and particles. HoloZcan develops of a novel holographic microscopy and imaging technology for rapid and cost-efficient screening of potential biological threats and unknown, potentially dangerous substances, combined with methods of artificial intelligence and machine learning. It establishes a framework of a dynamic feature selection and validation algorithm to support the continuous innovation capability of the system in the field of adaptive learning and database optimization for specific bioinformatic applications. The project also develops comprehensive and innovative means of respiratory, ventilation and environmental biological data sampling that can be used in real-time, standoff or in mobile bio-detection context. The project indicates the HoloZcan technique versatility for a wide range of applications and demonstrates its technical feasibility. The project responses to the actual needs of European practitioners and technological gaps identified by the ENCIRCLE project as indicated in the ENCIRCLE Catalogue of Technologies and addresses several shortcomings of the current approaches to bio-threat agent detection. The HoloZcan project applies a flexible adaptive approach to design and CBRN practitioners are engaged as project partners or as external stakeholders in the process.
more_vert assignment_turned_in ProjectFrom 2005Partners:GE, Institut Gustave Roussy, SUPELEC, Institute CurieGE,Institut Gustave Roussy,SUPELEC,Institute CurieFunder: French National Research Agency (ANR) Project Code: ANR-05-RNTS-0001Funder Contribution: 655,807 EURmore_vert assignment_turned_in ProjectFrom 2020Partners:HPSJ, CCML, INSERM Délégation Régionale Paris 11, INSERM - DELEGATION PARIS VI, JANSSEN-CILAG +6 partnersHPSJ,CCML,INSERM Délégation Régionale Paris 11,INSERM - DELEGATION PARIS VI,JANSSEN-CILAG,GE,AP-HP,Hôpital Marie Lannelongue,Université Paris-Saclay,Université de Paris XI (Paris Sud Orsay),Actelion pharmaceuticals FranceFunder: French National Research Agency (ANR) Project Code: ANR-18-RHUS-0006Funder Contribution: 5,053,600 EURmore_vert assignment_turned_in ProjectFrom 2024Partners:SIM&CURE, INSERM Délégation Grand Ouest, Université de Bordeaux, CHU Bordeaux, Fédération des Spécialités Médicales +5 partnersSIM&CURE,INSERM Délégation Grand Ouest,Université de Bordeaux,CHU Bordeaux,Fédération des Spécialités Médicales,GE,Inria Rennes - Bretagne Atlantique Research Centre,Medtronic (France),Medtronic (United States),MILVUEFunder: French National Research Agency (ANR) Project Code: ANR-23-RHUS-0013Funder Contribution: 551,004 EURmore_vert
chevron_left - 1
- 2
chevron_right